We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Blood Test to Measure Omega-3 Fatty Acids Could Help Evaluate Cardiovascular Risks

By LabMedica International staff writers
Posted on 13 Oct 2023

The human body can produce many of the fats it requires, but omega-3 fatty acids must come from our diet. More...

These essential fatty acids, specifically EPA and DHA, are mainly found in sources like fish, seafood, and certain enriched foods and supplements. A deficiency in these fatty acids can increase cardiovascular risks and is linked to issues like inflammation, mental decline, depression, and problems in fetal brain development and premature births. Currently, assessing omega-3 levels in the blood is challenging and involves an invasive blood test. Now, researchers have come up with a more convenient method to monitor these crucial fatty acids in the blood, making it easier to collect vital health data related to cardiovascular and cognitive health.

Researchers at McMaster University (Hamilton, ON, Canada) have identified a new biomarker for the Omega-3 Index (O3I) which makes it simpler to study the role of omega-3 fatty acid nutrition for overall public health, including among at-risk populations. Traditional methods for assessing O3I have involved drawing significant amounts of blood and complex lab procedures, making it an uncommon practice among healthcare providers. This new technique could enable regular screening, assisting both doctors and patients in determining the appropriate level of supplementation.

Generally, an O3I lower than 4% signifies a greater risk for cardiovascular issues, while an O3I above 8% suggests a lower risk. Importantly, the O3I can be modified through dietary changes. In the study, subjects were administered between 3 to 5 grams of fish oil, EPA, or DHA supplements daily. The research team conducted lipid profiling to pinpoint specific O3I biomarkers from the hundreds of lipids that can be found in the blood. The researchers are also working on identifying a substitute biomarker for the O3I through a urine test, which would eliminate the need for blood draws altogether.

“Our test can be part of a routine blood test without any special requirements,” says lead author Philip Britz-McKibbin, a professor of chemistry and chemical biology at McMaster. “By directly measuring only two specific biomarkers in a blood sample, we can rapidly assess the Omega-3 Index without time-consuming and costly sample workup protocols prior to analysis.”

Related Links:
McMaster University


Gold Member
STI Test
Vivalytic MG, MH, UP/UU
Online QC Software
Acusera 24•7
New
Urine Analyzer
respons® UDS100
New
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Originally designed for lung cancer detection and resistance monitoring, the test also shows potential for identifying signals linked to pulmonary fibrosis (image credit: iStock)

Urine-Based Nanosensor Tracks Lung Cancer and Fibrosis Noninvasively

Lung cancer remains difficult to monitor for early progression and treatment resistance, while pulmonary fibrosis continues to pose major challenges for early diagnosis. Clinicians need repeatable, noninvasive... Read more

Microbiology

view channel
Image: The findings suggest that people with mpox can transmit the virus even without clinical symptoms (image credit: Adobe Stock)

Study Finds Hidden Mpox Infections May Drive Ongoing Spread

Mpox continues to circulate despite vaccination, and many cases show no known link to a symptomatic partner. The role of people without symptoms has remained uncertain, limiting clarity on how transmission persists.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.